Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 114 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Doumas, Michael  [Clear All Filters]
Journal Article
Stavropoulos, K., Imprialos K. P., & Doumas M. (2017).  Abnormal blood pressure dipping in diabetic kidney disease: A black-race nightmare?. J Clin Hypertens (Greenwich). 19(12), 1336-1338.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2018).  Antihypertensive drug treatment: the real-life challenge.. J Clin Hypertens (Greenwich). 20(1), 115-117.
Boutari, C., Stavropoulos K., Imprialos K. P., Petidis K., & Doumas M. (2016).  Antihypertensive Drug-Related Side Effects: Is It the Unique Indicator for Nonadherence?. Am J Hypertens. 29(5), 662.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Antihypertensive therapy after acute ischemic stroke.. JAMA. 311(22), 2333-4.
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Doumas, M., Papademetriou V., Douma S., Faselis C., Tsioufis K., Gkaliagkousi E., et al. (2010).  Benefits from treatment and control of patients with resistant hypertension.. Int J Hypertens. 2011, 318549.
Doumas, M., Stavropoulos K. V., Boutari C., Imprialos K. P., & Karagiannis A. (2017).  Blood pressure and cardiovascular outcomes: a closer look.. Lancet. 389(10076), 1295-1296.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Doumas, M., Guo D., & Papademetriou V. (2009).  Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions.. Expert Opin Ther Targets. 13(4), 413-25.
Papademetriou, V., Doumas M., Faselis C., Tsioufis C., Douma S., Gkaliagkousi E., et al. (2011).  Carotid baroreceptor stimulation for the treatment of resistant hypertension.. Int J Hypertens. 2011, 964394.
Stavropoulos, K., Imprialos K. P., Doumas M., & Athyros V. G. (2018).  Carotid intima-media thickness as a target-organ damage and treatment-target: Need for a major revision?. J Clin Hypertens (Greenwich). 20(2), 255-257.
Papademetriou, V., Nylen E. S., Doumas M., Probstfield J., Mann J. F. E., Gilbert R. E., et al. (2017).  Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.. Am J Med. 130(12), 1465.e27-1465.e39.
Doumas, M., Imprialos Κ., Stavropoulos K., Reklou A., Sachinidis A., & Athyros V. G. (2018).  Combination of SGLT-2 inhibitors and GLP-1 receptor agonists: potential benefits in surrogate and hard endpoints.. Curr Pharm Des.
Nikolaidou, B., Lazaridis A., & Doumas M. (2014).  Combined angiotensin inhibition in diabetic nephropathy.. N Engl J Med. 370(8), 778-9.
Loutradis, C., Schoina M., Dimitroulas T., Doumas M., Garyfallos A., Karagiannis A., et al. (2020).  Comparison of ambulatory central hemodynamics and arterial stiffness in patients with diabetic and non-diabetic CKD.. J Clin Hypertens (Greenwich).
Kourtzelis, I., Markiewski M. M., Doumas M., Rafail S., Kambas K., Mitroulis I., et al. (2010).  Complement anaphylatoxin C5a contributes to hemodialysis-associated thrombosis.. Blood. 116(4), 631-9.
Imprialos, K. P., Boutari C., Stavropoulos K., Doumas M., Athyros V. G., & Karagiannis A. I. (2016).  Current challenges in antihypertensive treatment in the elderly.. Pol Arch Med Wewn. 126(7-8), 540-51.
Imprialos, K., Boutari C., Stavropoulos K., Doumas M., & Karagiannis A. I. (2016).  Depression in hypertensive patients: the role of comorbidities.. J Hypertens. 34(7), 1441.
Athyros, V. G., Doumas M., Imprialos K. P., Stavropoulos K., Georgianou E., Katsimardou A., et al. (2018).  Diabetes and lipid metabolism.. Hormones (Athens). 17(1), 61-67.
Athyros, V. Gabriel, Doumas M., & Karagiannis A. (2016).  Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action.. Indian Heart J. 68(5), 596-598.
Imprialos, K., Boutari C., & Doumas M. (2016).  Discontinuation of Antihypertensive Treatment in Elderly Patients and Cognitive Function.. JAMA Intern Med. 176(3), 409.
Triantafyllou, A., Doumas M., Anyfanti P., Gkaliagkousi E., Zabulis X., Petidis K., et al. (2013).  Divergent retinal vascular abnormalities in normotensive persons and patients with never-treated, masked, white coat hypertension.. Am J Hypertens. 26(3), 318-25.
Antza, C., Doundoulakis I., Akrivos E., Stabouli S., Trakatelli C., Doumas M., et al. (2018).  Early Vascular Aging Risk Assessment From Ambulatory Blood Pressure Monitoring: The Early Vascular Aging Ambulatory Score.. Am J Hypertens. 31(11), 1197-1204.
Doumas, M. (2014).  Editorial: interventional management of hypertension and cardiovascular disease: the beginning of a new era?. Curr Vasc Pharmacol. 12(1), 2-3.
Athyros, V. G., & Doumas M. (2018).  Editorial: Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis: An Epidemic that will Boost the Incidence of Cardiovascular Morbidity and Mortality.. Curr Vasc Pharmacol. 16(3), 206-208.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές